Tempest Therapeutics Inc (TPST) is higher by Monday morning, with the stock rising 3.83% in pre-market trading to 3.52. TPST's short-term technical score of 44 indicates that the stock has traded less bullishly over the last month than 56% of stocks on the market. In the Biotechnology industry, which ranks 86 out of 146 industries, Tempest Therapeutics Inc ranks higher than 55% of stocks. Tempest Therapeutics Inc has fallen 18.90% over the past month, closing at $4.32 on February 12. During this period of time, the stock fell as low as $3.16 and as high as $4.39. TPST has an average analyst recommendation of Strong Buy. The company has an average price target of $20.00.
News Home
Tempest Therapeutics Inc has a Long-Term Technical rank of 17. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 83% of the market scoring higher. In the Biotechnology industry which is number 51 by this metric, TPST ranks better than 51% of stocks.
Should You Hold Tempest Therapeutics Inc (TPST) Stock Monday Morning?
Mentioned in this article
TPST has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on TPST!